Aquilo Capital Management as of Dec. 31, 2022
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 13 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals (ARWR) | 16.8 | $45M | 1.1M | 40.56 | |
| S&p Biotech Etf Tr Unit Put Option (XBI) | 15.6 | $42M | 500k | 83.00 | |
| Blueprint Medicines (BPMC) | 9.6 | $26M | 582k | 43.81 | |
| Arvinas Ord (ARVN) | 8.7 | $23M | 674k | 34.21 | |
| Merus N V (MRUS) | 8.3 | $22M | 1.4M | 15.47 | |
| Regenxbio Inc equity us cm (RGNX) | 7.6 | $20M | 898k | 22.68 | |
| Silence Therapeutics Ads (SLN) | 7.4 | $20M | 1.3M | 15.25 | |
| Kymera Therapeutics (KYMR) | 5.9 | $16M | 629k | 24.96 | |
| Amryt Pharma Sponsored Ads | 5.8 | $15M | 2.1M | 7.30 | |
| Uniqure Nv SHS (QURE) | 5.3 | $14M | 625k | 22.67 | |
| Genmab A/s Sponsored Ads (GMAB) | 3.9 | $10M | 243k | 42.38 | |
| Argenx Se Sponsored Adr (ARGX) | 3.4 | $9.1M | 24k | 378.83 | |
| Pieris Pharmaceuticals | 1.8 | $4.7M | 4.6M | 1.04 |
